- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/197 - Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
Patent holdings for IPC class A61K 31/197
Total number of patents in this class: 2341
10-year publication summary
|
193
|
175
|
183
|
216
|
220
|
222
|
239
|
202
|
185
|
148
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| SBI Pharmaceuticals Co., Ltd. | 109 |
69 |
| The Regents of the University of California | 20230 |
39 |
| Pharnext | 87 |
37 |
| Société des Produits Nestlé S.A. | 9856 |
26 |
| Osmotica Kereskedelmi ES Szolgaltato Kft | 23 |
21 |
| DSM IP Assets B.V. | 5553 |
18 |
| Ovid Therapeutics Inc | 167 |
16 |
| Quadriga Biosciences, Inc. | 22 |
16 |
| ThermoLife International, LLC | 130 |
16 |
| Alpheus Medical, Inc. | 40 |
16 |
| University of Florida Research Foundation, Inc. | 4074 |
14 |
| Medisca Pharmaceutique Inc. | 140 |
14 |
| Jazz Pharmaceuticals Research UK Limited | 213 |
14 |
| Allergan, Inc. | 2315 |
13 |
| Amneal Pharmaceuticals LLC | 116 |
13 |
| Diamyd Medical AB, AKA Diamyd | 28 |
13 |
| National Center for Child Health and Development | 82 |
13 |
| Theravance Biopharma R&D IP, LLC | 453 |
12 |
| Centre National de La Recherche Scientifique | 10635 |
10 |
| Aldeyra Therapeutics, Inc. | 106 |
10 |
| Other owners | 1941 |